Decision: Favourable
Study Title:
A PHASE IIIB, MULTICENTER, RANDOMIZED, VISUAL ASSESSOR-MASKED STUDY OF THE EFFECTIVENESS AND SAFETY OF A 36-WEEK REFILL REGIMEN FOR THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB VS AFLIBERCEPT TREAT & EXTEND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DE
NREC Code:
22-NREC-CT-020
Decision:
Favourable
Study Type:
CT application
Principal Investigator:
Mr Mark Cahill
PI Institution:
Royal Victoria Eye and Ear Hospital
Sponsor:
Roche